Category: Therapeutic Area
Japan Therapeutic Area
-
2024 Japan Maternal Health Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Japan In-Vitro Fertilization (Ivf) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Japan Lung Cancer Surgery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Japan Chronic Kidney Disease (Ckd) Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Japan Pediatric Home Healthcare Services Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Japan Cosmetic Dentistry Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Japan Cannabis Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
Asia Pacific Corporate Wellness Market, By Service Type (Health Risk Assessment, Nutrition & Weight Management, Smoking Cessation, Fitness Services, Stress Management, Health Screening & Assessment, Employee Assistance Programs (EAPs)); By Delivery Model (On-site Programs, Off-site Programs); By Category (Fitness & Nutrition Consultants, Psychological Therapists, Organizations/Employers, Fitness & Medical Institutions); By End User (Small Scale Organizations, Medium Scale Organizations, Large Scale Organizations); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... of increasing prevalence of lifestyle-related diseases, a growing emphasis on employee productivity, and expanding wellness program offerings in workplaces. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Asia ... Read More
-
2024 Japan Cancer Biomarkers Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 Japan Cancer-Tumor Profiling Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 Japan Cancer Registry Software Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 Japan Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
Japan Dry Eye Disease Market Forecast 2024-2032
... reaching an expected revenue of $401.68 million by 2032. The rising prevalence of dry eye diseases in Japan is linked to modern lifestyle factors such as increased screen exposure and environmental pollution, which significantly contribute ... Read More
-
NRT Smoking Cessation Aids in Japan
... in 2024. However, due to the negative image of smoking and stricter regulation, the decline is only slow, and a certain level of demand is being maintained. Euromonitor International's NRT Smoking Cessation Aids in Japan ... Read More
-
Digestive Remedies in Japan
... digestive remedies is set to continue in Japan in 2024, although growth will not be as sharp as in 2023. Euromonitor International's Digestive Remedies in Japan report offers a comprehensive guide to the size and ... Read More
-
Paediatric Consumer Health in Japan
... cold and allergy remedies are expected to see above-average performances, benefiting from the sustained high incidence of various infectious diseases in 2024, such as COVID-19, colds, and flu, similar to adult products. Euromonitor International's Paediatric ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in Japan
... benefiting from the proliferation of various infectious diseases in this year, including COVID-19, colds, and influenza, there has been a lower pollen count than in the previous year, which is expected to drive a decline ... Read More
-
Japan Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F Japan generic drugs market is projected to witness a CAGR of 7.81% during the forecast period FY2024-FY2032, growing from USD ... Read More
-
2024 Global Respiratory Syncytial Virus (RSV) Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume ... Read More
-
2024 Global Chlamydia Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
2024 Global H. Pylori Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5-year test volume and sales forecasts ... Read More
-
2024 Global Papillomavirus (HPV) Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for ... Read More
-
2024 Global West Nile Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies Locations
... Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for West Nile tests performed in the following market segments: Hospitals Commercial/Private Labs Physician Offices Public Health Labs Please note: ... Read More
-
2024 Global Pneumonia Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
Research Assistance
